Enhanced inhibition by melatonin of α-adrenoceptor-induced aortic contraction and inositol phosphate production in vascular smooth muscle cells from spontaneously hypertensive rats

Journal of Hypertension

Volumn 16, Issue 3, 1998, Pages 339-347

  Wu, Lingyun ^a   Wang, Rui ^a   De Champlain, Jacques ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Antioxidant; Experimental hypertension; Inositol phosphates; Melatonin; Norepinephrine; Superoxide anion

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CATALASE; CYCLIC AMP; FORSKOLIN; FREE RADICAL; HYPOXANTHINE; INOSITOL PHOSPHATE; MELATONIN; MELATONIN RECEPTOR; NORADRENALIN; PRAZOSIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE; YOHIMBINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FORCE; ISOTOPE LABELING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0031951893     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816030-00011     Document Type: Article

References (40)

1. Zanoboni A, Zanoboni-Muciaccia W. Experimental hypertension in pinealectomized rats. Life Sci 1967; 6:2327-2331.
2. Holmes SW, Sugder D. The effect of melatonin on pinealectomy-induced hypertension in the rat. Br J Pharmacol 1976; 56:360-361.
3. Kawashima K, Miwa Y, Fujimoto K, Oohata H, Nishimo H, Koike H. Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin Exp Hypertens 1987; 9:1121-1131.
4. Brismar K, Hylander B, Eliasson K, Rossner S, Wetterberg L. Melatonin secretion related to side-effects of β-blockers from the central nervous system. Acta Med Scand 1988; 223:525-530.
5. Dubocovich ML. Melatonin receptors: are there multiple subtypes? [review]. Trends Pharmacol Sci 1995; 16:50-56.
6. Viswanathan M, Laitinen JT, Saavedre JM. Differential expression of melatonin receptors in spontaneously hypertensive rats. Neuroendocrinology 1992; 56:864-870.
7. Harlow HJ. Influence of the pineal gland and melatonin on blood flow and evaporative water loss during heat stress in rats. J Pineal Res 1989; 4:147-159.
8. Weekley LB. Melatonin-induced relaxation of rat aorta: interaction with adrenergic agonists. J Pineal Res 1991; 11:28-34.
9. Satake N, Oe H, Sawada T, Shibata S. The mode of vasorelaxing action of melatonin in rabbit aorta. Gen Pharmacol 1991; 22:219-221.
10. Weekley LB. Influence of melatonin on bovine pulmonary vascular and bronchial airway smooth muscle tone. Clin Auton Res 1995; 5:53-56.
11. Evans BK, Mason R, Wilson VG. Evidence for direct vasoconstrictor activity of melatonin in 'pressurized' segments of isolated caudal artery from juvenile rats. Naunyn Schmiedebergs Arch Pharmacol 1992; 346:362-365.
12. Krause DN, Barrios VE, Duckles SP. Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rats caudal artery. Eur J Pharmacol 1995; 276:207-213.
13. Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993; 19:59-66.
14. Hiroyuki J, Torii M, Suzuki T. Decreased Superoxide dismutase activity and increased Superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. Clin Exp Hypertens 1995; 17: 803-816.
15. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does Superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci USA 1991; 88:10045-10048.
16. Katusic ZS. Superoxide anion and endothelial regulation of arterial tone. Free Radic Biol Med 1996; 20:443-448.
17. Mesaros S, Grunfeld S, Bohr DF, Malinski T. Nitric oxide and Superoxide in heart and aorta from normotensive (WKY) and hypertensive (SHRSP) rats. FASEB J 1995; 9:A325-A329.
18. Auch-Schwelk W, Katusic ZS, Vanhoutte PM. Contractions to oxygenderived free radicals are augmented in aorta of the spontaneously hypertensive rat. Hypertension 1989; 13:859-864.
19. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walder L, Chuang J, et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18:1-11.
20. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
21. Piere C, Marra M, Moroni F, Recchioni R, Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci 1994; 15:PL271-PL276.
22. Barlow-Walden LR, Reiter RJ, Abe M, Pablos MI, Menendez-Pelaez A, Chen LD, et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995; 26:497-502.
23. Meister A. On the antioxidant effect of ascorbic acid and glutathion. Biochem Pharmacol 1992; 44:1905-1915.
24. Eid H, de Champlain J. Increased inositol monophosphate production in cardiovascular tissues of DOCA-salt hypertensive rats. Hypertension 1988; 12:122-128.
25. 2+ release from vascular smooth muscle sarcoplasmic reticulum. Am J Physiol 1992; 262:H114-H116.
26. Wang ZZ, Ma M, Wang R. Enhanced vasocontraction of rat tail artery by toxoflavin. Br J Pharmacol 1996; 117:293-298.
27. Wu L, de Champlain J. Inhibition by cAMP of basal and induced inositol phosphate production in cultured aortic smooth muscle cells from Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens 1996; 14:593-599.
28. Wang R, Karpinski E, Pang PKT. Two types of calcium channels in isolated smooth muscle cells from rat tail artery. Am J Physiol 1989; 256:H1361-H1368.
29. Dean NM, Beaven MA. Methods for the analysis of inositol phosphates [review]. Anal Biochem 1989; 183:199-209.
30. Gunther S, Alexander RW, Atkinson WJ, Gimbrone MA Jr. Functional angiotensin II receptors in cultured smooth muscle cells. J Cell Biol 1982; 92:289-298.
31. Gimsn AG. A protein binding assay for adenosine 3.5-monophosphate. Proc Natl Acad Sci USA 1970; 67:305-312.
32. Southorn PA, Powis G. Free radicals in medicine. I. chemical nature and biologic reactions. Mayo Clin Proc 1988; 63:381-389.
33. Dowell FJ, Hamilton CA, McMurray J, Reid JL Effects of xanthine oxidase/hypoxanthine free radical and reactive oxygen species generating system on endothelial function in New Zealand white rabbit. J Cardiovasc Pharmacol 1993; 22:792-797.
34. Peppert SM, Weaver DR, Gofdon C. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol Sci 1996; 17:100-102.
35. Ruffolo RR, Yaden EL. Existence of spare alpha 1-adrenoceptors, but not alpha 2-adrenoceptors, for respective vasopressor effects of ciarazoline and B-HT933 in the pithed rat. J Cardiovasc Pharmacol 1984; 6:1011-1019.
36. Stanko CK, Smyth DD. Proximal tubular α2-adrenoceptor density in the spontaneously hypertensive rat. Am J Hypertens 1991; 4:64-67.
37. Bylund DB, Ray-Prenger C. Alpha-2A and alpha-2B adrenergic receptor subtypes: attenuation of cyclic AMP production in cell lines containing only one receptor subtype. J Pharmacol Exp Ther 1989; 251:640-644.
38. 3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther 1994; 268:1362-1367.
39. Melchiorri D, Reiter RJ, Attia AM, Harass M, Burgos A, Gnostic G. Potent protective effect of melatonin on in vivo parquet-induced oxidative damage in rats. Life Sci 1994; 56:83-89.
40. Reiter RJ, Tan DX, Poeggeler B, Menendez-Pelaez A, Chen LD, Saarela S. Melatonin as a free radical scavenger: implications for aging and agerelated diseases. Ann N Y Acad Sci 1994; 719:1-12.